<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30964048</PMID><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1673-5374</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>8</Issue><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Neural regeneration research</Title><ISOAbbreviation>Neural Regen Res</ISOAbbreviation></Journal><ArticleTitle>Regenerative biomarkers for Duchenne muscular dystrophy.</ArticleTitle><Pagination><StartPage>1317</StartPage><EndPage>1320</EndPage><MedlinePgn>1317-1320</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/1673-5374.253534</ELocationID><Abstract><AbstractText>Skeletal muscle has an extraordinary capacity to regenerate after injury and trauma. The muscle repair mechanism is a complex process orchestrated by multiple steps. In neuromuscular disorders such as Duchenne muscular dystrophy (DMD), the pathological consequences of the lack of dystrophin and the loss of the dystrophin-associated protein complex are dramatic, with a progressive cascade of events, such as continual influx of inflammation, repeated cycles of degeneration and impaired regeneration. Thus, muscle regeneration is a hallmark of the disease and careful monitoring of regenerative processes with robust markers should provide useful information to the field. Since decades, several indices of regeneration such as centronucleation and fibre size have been commonly used. In the present review, we discuss the impaired regenerative process in DMD, the common and new indices of regeneration and their associated methodologies. We notably highlight the regenerative marker embryonic myosin as a robust indicator of muscle regeneration. We also describe new quantitative methodologies offering the possibility of using a panel of translational regenerative biomarkers to obtain a more complete view of the regeneration processes. Upregulation of utrophin, an autosomal and functional paralogue of dystrophin, is one of the most promising therapeutic strategies as it targets the primary cause of the disease and is applicable to all DMD patients regardless their genetic defects. As utrophin is a regeneration associated protein increased in dystrophic muscle, we discuss the correlation of utrophin levels after drug treatment with regeneration markers. The recent advances in technologies and complementary markers of muscle regeneration described in this review, provide an unprecedented opportunity to develop more robust utrophin DMD based strategies for all DMD patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guiraud</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>MDUK Oxford Neuromuscular Centre, Department of Physiology, Anatomy and Genetics, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Kay E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>MDUK Oxford Neuromuscular Centre, Department of Physiology, Anatomy and Genetics, Oxford, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/N010698/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Neural Regen Res</MedlineTA><NlmUniqueID>101316351</NlmUniqueID><ISSNLinking>1673-5374</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DMD</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">degeneration</Keyword><Keyword MajorTopicYN="N">embryonic myosin</Keyword><Keyword MajorTopicYN="N">methodologies</Keyword><Keyword MajorTopicYN="N">muscle repair</Keyword><Keyword MajorTopicYN="N">regeneration</Keyword><Keyword MajorTopicYN="N">utrophin</Keyword></KeywordList><CoiStatement>None</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30964048</ArticleId><ArticleId IdType="pmc">PMC6524502</ArticleId><ArticleId IdType="doi">10.4103/1673-5374.253534</ArticleId><ArticleId IdType="pii">NeuralRegenRes_2019_14_8_1317_253534</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Barthelemy F, Wein N. Personalized gene and cell therapy for Duchenne Muscular Dystrophy. Neuromuscul Disord. 2018;28:803&#x2013;824.</Citation><ArticleIdList><ArticleId IdType="pubmed">30224293</ArticleId></ArticleIdList></Reference><Reference><Citation>Baghdadi MB, Tajbakhsh S. Regulation and phylogeny of skeletal muscle regeneration. Dev Biol. 2018;433:200&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pubmed">28811217</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciciliot S, Schiaffino S. Regeneration of mammalian skeletal muscle. Basic mechanisms and clinical implications. Curr Pharm Des. 2010;16:906&#x2013;914.</Citation><ArticleIdList><ArticleId IdType="pubmed">20041823</ArticleId></ArticleIdList></Reference><Reference><Citation>Desguerre I, Christov C, Mayer M, Zeller R, Becane HM, Bastuji-Garin S, Leturcq F, Chiron C, Chelly J, Gherardi RK. Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up. PLoS One. 2009;4:e4347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2633042</ArticleId><ArticleId IdType="pubmed">19194511</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumont NA, Wang YX, von Maltzahn J, Pasut A, Bentzinger CF, Brun CE, Rudnicki MA. Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division. Nat Med. 2015;21:1455&#x2013;1463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4839960</ArticleId><ArticleId IdType="pubmed">26569381</ArticleId></ArticleIdList></Reference><Reference><Citation>Ervasti JM. Dystrophin, its interactions with other proteins, and implications for muscular dystrophy. Biochim Biophys Acta. 2007;1772:108&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">16829057</ArticleId></ArticleIdList></Reference><Reference><Citation>Ervasti JM. Dystrophin and utrophin quantitation using full-length recombinant protein as standard. Measuring Dystrophin in Dystrophinopathy Patients and Interpreting the Data, Scientific Workshop. 2015</Citation></Reference><Reference><Citation>Fisher R, Tinsley JM, Phelps SR, Squire SE, Townsend ER, Martin JE, Davies KE. Non-toxic ubiquitous over-expression of utrophin in the mdx mouse. Neuromuscul Disord. 2001;11:713&#x2013;721.</Citation><ArticleIdList><ArticleId IdType="pubmed">11595513</ArticleId></ArticleIdList></Reference><Reference><Citation>Guiraud S, Aartsma-Rus A, Vieira NM, Davies KE, van Ommen GJ, Kunkel LM. The pathogenesis and therapy of muscular dystrophies. Annu Rev Genomics Hum Genet. 2015;16:281&#x2013;308.</Citation><ArticleIdList><ArticleId IdType="pubmed">26048046</ArticleId></ArticleIdList></Reference><Reference><Citation>Guiraud S, David R, Davies KE. The potential of utrophin modulators for the treatment of Duchenne muscular dystrophy. Expert Opin Orphan Drugs. 2018;6:179&#x2013;192.</Citation></Reference><Reference><Citation>Guiraud S, Edwards B, Squire SE, Moir L, Berg A, Babbs A, Ramadan N, Wood MJ, Davies KE. Embryonic myosin is a regeneration marker to monitor utrophin based therapies for DMD. Hum Mol Genet. 2019;28:307&#x2013;319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6322073</ArticleId><ArticleId IdType="pubmed">30304405</ArticleId></ArticleIdList></Reference><Reference><Citation>Janghra N, Morgan JE, Sewry CA, Wilson FX, Davies KE, Muntoni F, Tinsley J. Correlation of utrophin levels with the dystrophin protein complex and muscle fibre regeneration in duchenne and becker muscular dystrophy muscle biopsies. PLoS One. 2016;11:e0150818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4790853</ArticleId><ArticleId IdType="pubmed">26974331</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleopa KA, Drousiotou A, Mavrikiou E, Ormiston A, Kyriakides T. Naturally occurring utrophin correlates with disease severity in Duchenne muscular dystrophy. Hum Mol Genet. 2006;15:1623&#x2013;1628.</Citation><ArticleIdList><ArticleId IdType="pubmed">16595608</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratt SJP, Valencia AP, Le GK, Shah SB, Lovering RM. Pre- and postsynaptic changes in the neuromuscular junction in dystrophic mice. Front Physiol. 2015;6:252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4563167</ArticleId><ArticleId IdType="pubmed">26441672</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiaffino S, Gorza L, Dones I, Cornelio F, Sartore S. Fetal myosin immunoreactivity in human dystrophic muscle. Muscle Nerve. 1986;9:51&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">3513005</ArticleId></ArticleIdList></Reference><Reference><Citation>Turk R, Sterrenburg E, de Meijer EJ, van Ommen GJ, den Dunnen JT, &#x2018;t Hoen PA. Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling. BMC Genomics. 2005;6:98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1190170</ArticleId><ArticleId IdType="pubmed">16011810</ArticleId></ArticleIdList></Reference><Reference><Citation>Weir AP, Morgan JE, Davies KE. A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration. Neuromuscul Disord. 2004;14:19&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">14659408</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Hu P. Skeletal muscle regeneration is modulated by inflammation. J Orthop Translat. 2018;13:25&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5892385</ArticleId><ArticleId IdType="pubmed">29662788</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>